Academic journals

TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund

Retrieved on: 
Monday, September 6, 2021

(Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company ("Ambix Ventures").

Key Points: 
  • (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company ("Ambix Ventures").
  • TANAKA provides precious metal components and materials to medical device manufacturers and participates in development projects, cooperating with and contributing to development in the healthcare field.
  • About Ambix Life Science Fund and Aaron Berez, MD
    Ambix Life Science Fund I, L.P. is a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company.
  • Overview of Ambix Life Science Fund I, L.P.
    Fund name: Ambix Life Science Fund I, L.P., a Delaware limited partnership
    The fund is a relatively new fund based around a long-standing syndicate of medical device investors.

Stryker declares a $0.63 per share quarterly dividend

Retrieved on: 
Wednesday, August 4, 2021

Kalamazoo, Michigan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable October 29, 2021 to shareholders of record at the close of business on September 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.

Key Points: 
  • Kalamazoo, Michigan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable October 29, 2021 to shareholders of record at the close of business on September 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.
  • Stryker is one of the worlds leading medical technology companies and, together with its customers, is driven to make healthcare better.
  • The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
  • For investor inquiries please contact:
    For media inquiries please contact:

OrthoPediatrics Corp. and Mighty Oak Medical Extend Exclusive Partnership for FIREFLY Technology in Pediatric Orthopedics

Retrieved on: 
Wednesday, August 4, 2021

Since August 2017, OrthoPediatrics has been the exclusive distributor of Mighty Oak Medicals FIREFLY Technology in childrens hospitals across the United States.

Key Points: 
  • Since August 2017, OrthoPediatrics has been the exclusive distributor of Mighty Oak Medicals FIREFLY Technology in childrens hospitals across the United States.
  • Manufactured by Might Oak Medical, FIREFLY Pedicle Screw Navigation Guides are 3D printed and patient-specific at each planned vertebral level.
  • OrthoPediatrics regards this partnership as a great synergy and has enjoyed working with Mighty Oak Medical to make scoliosis easier for surgeons, and surgery safer for KIDS.
  • OrthoPediatrics Chief Financial Officer, and Chief Operating Officer Fred Hite, said, We are delighted to continue our partnership with Mighty Oak Medical.

Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

Retrieved on: 
Tuesday, August 3, 2021

LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Melinda Litherland to its board of directors.

Key Points: 
  • LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Melinda Litherland to its board of directors.
  • She also serves on the board of directors at Bio-Rad Laboratories, Inc., chairing the audit committee.
  • We are thrilled to welcome a board member with Melindas extensive financial and life sciences background to Rapid Micro Biosystems, said President and CEO Robert Spignesi.
  • I am excited to join the board at Rapid Micro Biosystems at an energizing time in the company's growth, Litherland said.

Certis Biologicals Names Claudia Oceguera Chief Administrative Officer

Retrieved on: 
Tuesday, August 3, 2021

Certis Biologicals today announced Claudia Oceguera as Chief Administrative Officer.

Key Points: 
  • Certis Biologicals today announced Claudia Oceguera as Chief Administrative Officer.
  • View the full release here: https://www.businesswire.com/news/home/20210803005142/en/
    Claudia Oceguera, Certis Biologicals Chief Administrative Officer (Photo: Business Wire)
    Before joining Certis Biologicals, Oceguera spent more than 20 years at FMC Corporation and most recently oversaw financial management, oversight, planning and investment analysis of the companys $350 million dollar innovation and global marketing pipeline, while overseeing a team of finance professionals around the world.
  • The addition of Claudia to our leadership team will be an asset as Certis rises to meet the challenges of the growing biologicals marketplace.
  • Certis Biologicals is the leader in manufacturing and distributing biologicals with partnerships and relationships that span the globe, says Oceguera.

Excision BioTherapeutics Appoints Industry Veteran Lisa Danzig, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, July 29, 2021

SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced the appointment of Lisa Danzig, M.D., as Chief Medical Officer.

Key Points: 
  • SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced the appointment of Lisa Danzig, M.D., as Chief Medical Officer.
  • Most recently, she has worked with Pandefense Advisory helping various institutions, non-profits, companies, and governments around the world on COVID-19 responses and protocols.
  • Dr. Danzig previously served as EVP and Chief Medical Officer at infectious disease and travel vaccine developer, PaxVax.
  • Excision BioTherapeutics, Inc., is a biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases.

Feinstein Institutes’ Research Journal Molecular Medicine Increases Impact Factor

Retrieved on: 
Thursday, July 29, 2021

The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.

Key Points: 
  • The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.
  • Impact factors help inform fellow researchers about the reach and influence a medical journal has on the larger scientific community and why they should consider submitting their studies for publication, said Betty Diamond, MD, director of the Institute of Molecular Medicine at the Feinstein Institutes and Editor-in-Chief of Molecular Medicine.
  • In addition to Molecular Medicine, the Feinstein Institutes publishes the journal Bioelectronic Medicine in partnership with BioMed Central , part of Springer Nature .
  • Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

India Macroeconomic Environment Outlook Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 26, 2021

The "India's Macroeconomic Environment Outlook, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India's Macroeconomic Environment Outlook, 2021" report has been added to ResearchAndMarkets.com's offering.
  • The Indian economy was forecast to record an 11.3% growth in 2021-22, based on prevailing conditions in March 2021.
  • Since then, however, the economic outlook has changed with the start of the 2nd wave of COVID-19.
  • India has emerged as an alternative, and this will fuel the government's vision of boosting domestic production.

Four Nurses Honored with Journal of Emergency Nursing Awards

Retrieved on: 
Monday, July 26, 2021

SCHAUMBURG, Ill., July 26, 2021 /PRNewswire/ --The Emergency Nurses Association on Monday marked the fifth year of the Journal of Emergency Nursing awards with the announcement of the 2021 Reviewers of the Year and Author of the Year recipients.

Key Points: 
  • SCHAUMBURG, Ill., July 26, 2021 /PRNewswire/ --The Emergency Nurses Association on Monday marked the fifth year of the Journal of Emergency Nursing awards with the announcement of the 2021 Reviewers of the Year and Author of the Year recipients.
  • JEN is ENA's official peer-reviewed journal that features original research and updates from the emergency nursing field, while also covering practice and professional issues.
  • The 2021 Journal of Emergency Nursing award recipients will be recognized during Emergency Nursing 2021 A Hybrid Xperience, which will be held in Orlando, Florida, and virtually, Sept. 22-25.
  • The Emergency Nurses Association is the premier professional nursing association dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, and leadership.

The American Journal of Managed Care® (AJMC®) Celebrates the 10th Anniversary of Patient-Centered Oncology Care® (PCOC®) Conference

Retrieved on: 
Wednesday, July 21, 2021

CRANBURY, N.J., July 21, 2021 /PRNewswire/ --The American Journal of Managed Care (AJMC), the leading multimedia peer-reviewed journal dedicated to issues in managed care, marks a new year and decade for its annual conference and is thrilled to celebrate the 10th annual Patient-Centered Oncology Care (PCOC) conference, marking 10 years of success and connecting hundreds of payers, providers and key stakeholders within the oncology health care space.

Key Points: 
  • CRANBURY, N.J., July 21, 2021 /PRNewswire/ --The American Journal of Managed Care (AJMC), the leading multimedia peer-reviewed journal dedicated to issues in managed care, marks a new year and decade for its annual conference and is thrilled to celebrate the 10th annual Patient-Centered Oncology Care (PCOC) conference, marking 10 years of success and connecting hundreds of payers, providers and key stakeholders within the oncology health care space.
  • "Celebrating the 10th anniversary of PCOC represents a decade of the positive influence this conference has made on the oncology care industry," said Mike Hennessy Jr., president and CEO of MJH Life Sciences, parent company of AJMC.
  • The schedule for the 2-day event incorporates conference sessions and presentations from keynote speakers that will provide attendees with the most up-to-date information regarding the oncology care industry.
  • The American Journal of Managed Care (AJMC) is a multimedia,peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers.